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ABSTRACT
To facilitate the assessment of the safety profile of rotavirus vaccines effectively, baseline data on intus-
susception are important for comparison with intussusception rates following the introduction of vaccine. 
The aim of the study was to describe epidemiological and clinical features of intussusception in children 
aged less than five years in an Indian medical facility. Hospital data on intussusception for children dis-
charged during 1 January 2001–30 June 2004 from the Christian Medical College Hospital, Vellore, India, 
were reviewed. Relevant information was extracted from medical records to classify cases according to the 
criteria of the Brighton Collaboration Intussusception Working Group. Complete review of medical records 
for clinical and demographic information was only performed for those cases fulfilling level 1 diagnos-
tic certainty (definite intussusception) (Study ID 101245). During the surveillance period, 31 infants and 
children with definite intussusception were identified. The majority (61.2%) of the cases occurred in the 
first year of life. The male : female ratio was 3.4 : 1. Intussusception cases occurred round the year with no 
distinct seasonality. No intussusception-associated death was recorded. This study provides baseline data 
on intussusception in South India. Cases identified in the study were similar in presentation and demo-
graphics as those observed in other Asian settings. Prospective surveillance systems, using standardized case 
definitions will further increase the understanding of the aetiology and epidemiology of intussusception, 
especially as new rotavirus vaccines are made available. 
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INTRODUCTION
Intussusception is the most common cause of 
acute intestinal obstruction in infants and young 
children (1), with approximately two-thirds of all 
intussusceptions in children occurring among in-
fants aged less than one year. Some cases of intus-
susception resolve spontaneously and, if treated 
early, most can be reduced by oenema or surgery, 
and if untreated, most have fatal outcomes (2). 
Anatomic conditions triggering intussusception 
are discovered in less than 15% of cases. Viruses, 
such as adenovirus and enterovirus, have been as-
sociated with some cases (3). 
Mortality caused by intussusception in infants and 
children is now uncommon in developed countries 
due to better access to healthcare facilities. In con-
trast, intussusception-associated mortality remains 
high in some developing countries (1). A recent 
and extensive review by the World Health Organi-
zation (WHO) on intussusception concluded that, 
in developed countries, the baseline incidence of 
intussusception is between 0.5 and 4.3 cases per 
1,000 livebirths or 0.7-1.2 cases per 1,000 children 
aged less than one year (4). Accurate estimates of 
the incidence of intussusception are not available 
for most developing countries (1).
In recent years, intussusception has attracted ad-
ditional attention of the paediatric medical and 
public-health community because of its association Bhowmick K et al. Intussusception in Indian children
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observed in the United States with the first-licensed 
rotavirus vaccine—the rhesus-human reassortant 
rotavirus tetravalent (RRV-TV) vaccine (5,6)—and 
the ensuing recommendations for its suspension 
nine months after its introduction (7). These events 
raised serious questions about the further develop-
ment of other rotavirus candidates.  
Rotavirus is the most common cause of severe di-
arrhoea among infants and young children (8), 
resulting in approximately 600,000 to 850,000 
deaths annually worldwide (1). In India, rotavirus-
associated acute gastroenteritis accounts for 5-70% 
of all hospitalizations. About 20-30% of total hospi-
talizations are due to rotavirus-associated diarrhoea 
in early childhood (9). As a result of substantial 
morbidity and mortality worldwide caused by ro-
tavirus, the WHO and Global Alliance for Vaccines 
and Immunization (GAVI) have identified rotavi-
rus vaccines as a priority for development (10) and 
subsequent introduction (11). 
Although clinical studies have demonstrated the 
next generation of rotavirus vaccines to be safe (12), 
baseline knowledge of the clinical presentation, 
treatment outcomes, and epidemiology of intus-
susception in infants and children in India, prior to 
the introduction of vaccine, is critically important 
because it will better inform interpretation  of data 
on intussusception collected after these vaccines 
become available (4). 
This study outlines the clinical presentation, detec-
tion, seasonality, management, and outcome of in-
tussusception in young children aged less than five 
years in Vellore, India.
MATERIALS AND METHODS
This  retrospective  hospital-based  study  to  review 
cases of intussusception was carried out at the 
Christian Medical College (CMC) Hospital, Vellore, 
India. The CMC, Vellore, occupies a prominent 
place among healthcare institutions in India. It is 
a 2,234-bed multispeciality, tertiary-care teaching 
hospital, which consists of a vital, diverse, and in-
ter-denominational community (13). The protocol 
received appropriate institutional ethical review.  
Surveillance to identify cases of intussusception 
was planned for three complete years. However, 
the investigators included four subjects beyond 
the defined surveillance period, and therefore, the 
study period was extended up to June 2004. During 
1 January 2001–30 June 2004, cases of intussuscep-
tion were identified among hospitalized children 
aged less than five years. 
A case was identified in a two-step process: Pos-
sible cases of intussusception were first identified 
by searching radiology, pathology and computer-
ized discharge-records of hospital for the diagnoses 
based on the International Classification of Dis-
eases, Ninth and Tenth Revision, Clinical modifi-
cation codes for intussusception (ICD-9 CM), and 
intestinal obstruction (ICD-10 CM). The diagnosis 
of intussusception was then confirmed by review-
ing the medical records.  
Once a potential case was identified, the study 
medical officer reviewed the medical records 
of the child. Cases of intussusception, which 
met the case definition with level 1 diagnostic 
certainty by the criteria (surgical/radiological/ 
autopsy) of the Brighton Collaboration Intus-
susception Working Group, were included in the 
study (6).
Abstracted data included demographic informa-
tion, clinical manifestations, past medical history, 
including diagnostic procedures, treatment, and 
patient outcomes. The data were analyzed using 
the SAS software (version 8.2). 
RESULTS
In total, 32 cases of intussusception in the age-
group of 0-5 year(s) were identified during the sur-
veillance period; one case was excluded from analy-
sis as the child was diagnosed with intussusception 
exclusively based on clinical signs and symptoms. 
Hence, 31 definite cases of intussusception were 
considered for analysis. 
The median age of subjects was nine (range 1-55) 
months. The majority (61.2%) of these cases were 
infants with a peak between 6 and 12 months of 
age (Fig. 1). The male : female ratio was 3.4 : 1. A 
male preponderance was observed (24 males, 7 fe-
males). All the subjects were Indians.
Intussusception cases occurred round the year with 
no distinct seasonality (Fig. 2). Vomiting (26 cases; 
83.9%), pain in the abdomen (23 cases; 74.2%), 
abdominal mass (19 cases; 61.3%), and red 
currant jelly stool (13 cases; 41.9%) were the most 
frequently-recorded clinical signs and symptoms 
(Table 1). Of the 31 infants and children with in-
tussusception, four (12.9%) had a past history of 
gastrointestinal emergencies. Overall, four cases 
had received vaccination within the month pre-
ceding hospitalization: the first against diphtheria-
tetanus-pertussis (DTP), polio (OPV), Haemophilus 
influenzae (Hib), and hepatitis B (HBV); the second 
against DTP; the third against measles; and the Bhowmick K et al. Intussusception in Indian children
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fourth against DTP and OPV. However, for 22 cases, 
recent vaccination history was unknown. Thirty-
two percent (10/31) of the cases presented to the 
hospital for treatment beyond two days from the 
onset of symptoms (Table 2).
Less than half (41.9%) of the intussusception cases were 
diagnosed by barium enema, although diagnosis fol-
lowing surgical procedure was still common (35.5%). 
Other cases were diagnosed either by a combination of 
these two procedures (12.9%) or barium enema com-
Fig. 1. Age distribution of intussusception cases in children aged less than 5 years  in CMC Hospital,
           Vellore, India (January 2001–June 2004)
CMC=Christian Medical College 
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Fig. 2.   Seasonality of intussusception cases in CMC, Hospital, Vellore, India, January 2001–December 2003  * 
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bined with ultrasound (6.5%). Diagnosis exclusively 
by ultrasound only occurred in 3.2% of the cases. 
Surgical intervention was required in 20 cases 
(64.5%), radiological reduction in 10 cases (32.3%), 
and a combination of these two procedures in one 
case (3.2%). The median duration of hospitaliza-
tion for the intussusception cases in this study was 
5.0 (range 1-13) days. One patient was admitted to 
the Intensive Care Unit. All intussusception cases 
resolved, and no death was recorded.
DISCUSSION
Our study retrospectively analyzed 3.5 years of in-
tussusception data in the CMC Hospital, Vellore, 
India. Although there are a few private hospitals 
with modern facilities in the surrounding areas of 
Vellore, most middle- and lower-class children liv-
ing in this area would have been seen at the CMC 
Hospital. In addition, the CMC Hospital is a tertiary 
referral centre in India and, therefore, receives pae-
diatric referral cases from surrounding areas as well.
In many countries, incidence data in hospital-based 
studies are hard to obtain because denominator 
populations are not available to match numerator 
data, such as on hospitalizations. Similarly, in our 
study, the denominator of births was unavailable 
and would, in any case, have been subject to under-
ascertainment owing to the high proportion of 
childbirths in the home. Furthermore, the catch-
ment area for numerator cases of intussusception 
was difficult to define because of referrals to the 
CMC Hospital from other hospitals in Vellore and 
the surrounding towns. For these reasons, inci-
dence was not estimated. Further research, includ-
ing details of local healthcare-seeking behaviour, 
would be required to enable an estimate of popu-
lation-based incidence rates of health events, such 
as intussusception.
Nonetheless, these data from a three-year period 
provide a reasonable baseline for occurrence of in-
tussusception in this area. If we make the reason-
able assumption that the catchment population 
served by the CMC Hospital will remain stable, this 
baseline will still be useful for the evaluation of in-
tussusception trends in the future. 
Meanwhile, this study usefully describes the epi-
demiological pattern of intussusception in Vellore. 
Male predominance, which is observed globally 
and in previous studies conducted in Asia (1), is re-
affirmed in this study. No clear seasonality trend 
was observed in our study, which is consistent with 
reports from other studies (14,15). In this study, the 
classic triad of abdominal pain, vomiting, and rec-
tal bleeding was not the typical clinical manifesta-
tions in the intussusception cases. However, clini-
cal signs and symptoms in our study population 
were similar to those reported previously in other 
studies (16). Vomiting was the most common clini-
cal symptom. Its absence makes the diagnosis of 
intussusception unlikely. Over half of the subjects 
sought  medical  attention  beyond  two  days  after 
onset of the disease. The frequency of late presen-
tation led to a relatively high rate of surgery, with 
over one-third of the cases being diagnosed only 
at surgery and almost two-thirds requiring surgical 
intervention.
The retrospective nature of this study does mean 
that it has some limitations. First, it is unclear 
how inter-hospital transfers and re-admissions for 
the same intussusception episode are identified to 
avoid duplication of cases (17). Second, our study 
was limited by the lack of complete immunization 
data which made it difficult to reliably count the 
number of immunizations given prior to hospi-
Table 1. Clinical signs and symptoms reported 
among 31 intussusception cases in 
CMC Hospital, Vellore, India (January 
2001–June 2004)
Clinical feature %
Abdominal mass 61.3
Pain in abdomen 74.2
Diarrhoea 19.4
Fever 22.6
Red currant jelly stool 41.9
Vomiting 83.9
Other 71.0
CMC=Christian Medical College
Table 2. Distribution of days between onset of 
symptoms of intussusception and ad-
mission to hospital
Days between onset 
and admission
No. of cases % of cases
0 4 12.9
1 9 29.0
2 8 25.8
3 4 12.9
5 4 12.9
7 1 3.2
8 1 3.2Bhowmick K et al. Intussusception in Indian children
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talization for intussusception. This was, however, 
not a main objective of the study. Finally, our study 
was limited by the inability to define the catch-
ment area for intussusception cases or to obtain 
accurate birth-cohort data for the catchment popu-
lation. Nevertheless, the strength of this retrospec-
tive study is that it analyzed data from a tertiary 
hospital with complete investigation and reliable 
documentation, and cases of intussusception were 
ascertained using a standard case definition. The 
specificity of case ascertainment is, therefore, likely 
to be high, and the description of clinical presen-
tation, treatment outcomes, and epidemiology is 
consequently an accurate representation of intus-
susception in the population in Vellore.
The study provides important insights into the 
epidemiology of intussusception among southern 
Indian children. Although the next generation of 
licensed rotavirus vaccines show no association 
with intussusception (18,19), this does not negate 
the need for post-marketing surveillance which 
would provide re-assuring further confirmation of 
their safety—this study provides baseline data to 
facilitate further surveillance in this area.
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